Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-10-25 13:45:40 |
Versijas komentārs | |
Teksts |
Olaine, October 25, 2014
„Olainfarm”
Goes on Baltic – Nordic Roadshow
During October 27-31 representatives of AS „Olainfarm” will go on a
roadshow to update Baltic and Nordic investors about company’s
recent performance, current status and future
prospects.
„An ongoing communication with investors in a manner most
convenient for them is a cornerstone of good investor relations,
therefore we provide monthly updates on our sales development,
deliver timely disclosures and talk to our investors in our
quarterly webinars. However, all of that is a distant communication
that can not replace relationships that can only be established in
live meetings. Therefore we are going on this roadshow, so we
not only present our story, but listen to investors and understand
what their expectations are,” says Salvis Lapins, Member of the
Board of AS „Olainfarm”, Head of company’s Investor relations.
The investors will be introduced to the enclosed presentation, that
pays particular attention to company’s operations in Russia and
Ukraine as well as to company’s CAPEX
programme.
JSC Olainfarm is
one of the biggest pharmaceutical companies in Latvia with more
than 40 years of experience in production of medication and
chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 35 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia
Information
prepared by:
|
Pielikumi |